ENTITY
Moderna

Moderna (MRNA US)

78
Analysis
Health CareUnited States
Moderna, Inc. operates as a biotechnology company. The Company focuses on the discovery and development of messenger RNA therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
more
bullishJapan Airlines
17 Nov 2020 09:27

Japan Airlines Placement - Tricky Tricky, Needs to Correct

Japan Airlines (9201 JP) plans to raise around US$1.4bn in order to shore up its balance sheet and aid its longer term transformation.

Logo
238 Views
Share
bullishCureVac NV
13 Nov 2020 08:28

Success of Moderna’s COVID-19 Vaccine May Give a Boost to Stocks of Messenger RNA Companies

mRNA-based COVID-19 vaccine producers made a big step forward to defeat coronavirus and prevent future pandemics around the world

Logo
338 Views
Share
bullishCureVac NV
28 Sep 2020 04:21

Expecting First Results From Phase 1 Clinical Trials Of COVID-19 Vaccine In October

CureVac shares have been under selling pressure and fell ~20% in September. For the same period shares of key rivals Moderna and BioNTech rose 7%...

Logo
341 Views
Share
bullishCureVac NV
17 Aug 2020 21:37

How High Can CureVac Stock Go After Blockbuster IPO? We Update Bull Case Scenario to $80 Per Share

CureVac stock closed at $55.90 per share during the first trading day, the best performance among biotech IPOs this year. Since the beginning of...

Logo
580 Views
Share
bullishCureVac NV
14 Aug 2020 22:26

CureVac IPO. Beating Rivals to Secure a COVID-19 Vaccine Based on MRNA Technology

German global clinical-stage biotech company and coronavirus vaccine developer CureVac set terms for $200M+ IPO (~13.3 million shares) at a...

Logo
519 Views
Share
x